Developed skills and lines of research
Vito Terlizzi worked as a medical student at the Department of Pediatrics, Federico II University of Naples, from March 2005 to June 2009 in the Pediatric Hepatology sector and graduated in July 2008. He began his postgraduate school in pediatrics in May 2010. From September 2009, he carried out clinical research at the Pediatric Cystic Fibrosis Center in Naples, until the end of his specialization in pediatrics in 2015. Since February 2016, Dr. Terlizzi has been a pediatric physician at the Meyer Children’s Hospital, working full-time at the Cystic Fibrosis Center. Dr. Terlizzi has coordinated multicenter studies on genotype-phenotype correlation in cystic fibrosis, collaborating closely with the Department of Molecular Medicine and Medical Biotechnologies, the University of Naples Federico II and CEINGE, Naples (Prof. Giuseppe Castaldo). He is an active member of the SIFC (Italian Cystic Fibrosis Society) genetic group and since 2016 a member of the SIFC research commission. His most recent research activity concerns an epidemiological study on uncertain diagnoses of CF after neonatal CF screening.
Projects funded by FFC Ricerca as Principal Investigator or as Research Manager
FFC#24/2020
Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): an Italian multicenter survey evaluating prevalence, clinical data, management and outcome
FFC#30/2018
Cystic Fibrosis screen positive inconclusive diagnosis (CFSPID): an italian multicenter survey evaluating prevalence, clinical data, management and outcome
Publications from FFC Research projects
Terlizzi V, Claut L, Tosco A, Colombo C, Raia V, Fabrizzi B, Lucarelli M, Angeloni A, Cimino G, Castaldo A, Marsiglio L, Timpano S, Cirilli N, Moroni L, Festini F, Piccinini P, Zavataro L, Bonomi P, Taccetti G, Southern KW, Padoan R. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres. J Cyst Fibros. 2021 Apr 18:S1569-1993(21)00097-7. doi: 10.1016/j.jcf.2021.03.015. Epub ahead of print. PMID: 33883100.
Terlizzi V, Padoan R, Claut L, Colombo C, Fabrizzi B, Lucarelli M, Bruno SM, Castaldo A, Bonomi P, Taccetti G, Tosco A. CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development? Diagnostics (Basel). 2020 Dec 12;10(12):1080. doi: 10.3390/diagnostics10121080. PMID: 33322690; PMCID: PMC7764752.
Taccetti G, Botti M, Terlizzi V, Cavicchi MC, Neri AS, Galici V, Mergni G, Centrone C, Peroni DG, Festini F. Clinical and Genotypical Features of False-Negative Patients in 26 Years of Cystic Fibrosis Neonatal Screening in Tuscany, Italy. Diagnostics (Basel). 2020 Jul 1;10(7):446. doi: 10.3390/diagnostics10070446. PMID: 32630227; PMCID: PMC7399885.
Terlizzi V, Mergni G, Buzzetti R, Centrone C, Zavataro L, Braggion C. Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, Italy. J Cyst Fibros. 2019 Jul;18(4):484-490. doi: 10.1016/j.jcf.2019.04.002. Epub 2019 Apr 18. PMID: 31005549.
Terlizzi V, Mergni G, Centrone C, Festini F, Taccetti G. Trend of sweat chloride values in a cohort of patients carrying CFTR mutations of varying clinical consequence: Is there a risk of increasing sweat chloride over time? Pediatr Pulmonol. 2020 May;55(5):1089-1093. doi: 10.1002/ppul.24721. Epub 2020 Mar 9. PMID: 32150665.
Terlizzi V, Mergni G, Buzzetti R, et al. Cystic Fibrosis Screen Positive Inconclusive Diagnosis (CFSPID): Experience in Tuscany, Italy. J Cyst Fibros, 18 (4), 484-490 Jul 2019.